257 related articles for article (PubMed ID: 19815819)
1. High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis.
Skajaa T; Cormode DP; Falk E; Mulder WJ; Fisher EA; Fayad ZA
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):169-76. PubMed ID: 19815819
[TBL] [Abstract][Full Text] [Related]
2. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression.
Chen W; Cormode DP; Vengrenyuk Y; Herranz B; Feig JE; Klink A; Mulder WJ; Fisher EA; Fayad ZA
JACC Cardiovasc Imaging; 2013 Mar; 6(3):373-84. PubMed ID: 23433925
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
Shen ZT; Zheng S; Gounis MJ; Sigalov AB
PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
[TBL] [Abstract][Full Text] [Related]
4. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis.
Marrache S; Dhar S
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9445-50. PubMed ID: 23671083
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging.
Mulder WJ; Strijkers GJ; van Tilborg GA; Cormode DP; Fayad ZA; Nicolay K
Acc Chem Res; 2009 Jul; 42(7):904-14. PubMed ID: 19435319
[TBL] [Abstract][Full Text] [Related]
7. Modified lipoproteins as contrast agents for imaging of atherosclerosis.
Frias JC; Lipinski MJ; Lipinski SE; Albelda MT
Contrast Media Mol Imaging; 2007; 2(1):16-23. PubMed ID: 17318917
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis.
Chen W; Vucic E; Leupold E; Mulder WJ; Cormode DP; Briley-Saebo KC; Barazza A; Fisher EA; Dathe M; Fayad ZA
Contrast Media Mol Imaging; 2008; 3(6):233-42. PubMed ID: 19072768
[TBL] [Abstract][Full Text] [Related]
9. The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis.
Skajaa T; Cormode DP; Jarzyna PA; Delshad A; Blachford C; Barazza A; Fisher EA; Gordon RE; Fayad ZA; Mulder WJ
Biomaterials; 2011 Jan; 32(1):206-13. PubMed ID: 20926130
[TBL] [Abstract][Full Text] [Related]
10. Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages.
Sigalov AB
Contrast Media Mol Imaging; 2014; 9(5):372-82. PubMed ID: 24729189
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice.
Jung C; Kaul MG; Bruns OT; Dučić T; Freund B; Heine M; Reimer R; Meents A; Salmen SC; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
Circ Cardiovasc Imaging; 2014 Mar; 7(2):303-11. PubMed ID: 24357264
[TBL] [Abstract][Full Text] [Related]
12. Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis.
Cormode DP; Chandrasekar R; Delshad A; Briley-Saebo KC; Calcagno C; Barazza A; Mulder WJ; Fisher EA; Fayad ZA
Bioconjug Chem; 2009 May; 20(5):937-43. PubMed ID: 19378935
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles.
Cormode DP; Roessl E; Thran A; Skajaa T; Gordon RE; Schlomka JP; Fuster V; Fisher EA; Mulder WJ; Proksa R; Fayad ZA
Radiology; 2010 Sep; 256(3):774-82. PubMed ID: 20668118
[TBL] [Abstract][Full Text] [Related]
14. Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging.
Frias JC; Ma Y; Williams KJ; Fayad ZA; Fisher EA
Nano Lett; 2006 Oct; 6(10):2220-4. PubMed ID: 17034087
[TBL] [Abstract][Full Text] [Related]
15. Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression.
Chalmers AD; Bursill CA; Myerscough MR
PLoS One; 2017; 12(11):e0187674. PubMed ID: 29161303
[TBL] [Abstract][Full Text] [Related]
16. HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages.
Sanchez-Gaytan BL; Fay F; Lobatto ME; Tang J; Ouimet M; Kim Y; van der Staay SE; van Rijs SM; Priem B; Zhang L; Fisher EA; Moore KJ; Langer R; Fayad ZA; Mulder WJ
Bioconjug Chem; 2015 Mar; 26(3):443-51. PubMed ID: 25650634
[TBL] [Abstract][Full Text] [Related]
17. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.
den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G
Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907
[TBL] [Abstract][Full Text] [Related]
18. Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.
Ala-Korpela M; Sipola P; Kaski K
Ann Med; 2006; 38(5):322-36. PubMed ID: 16938802
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance.
Li D; Patel AR; Klibanov AL; Kramer CM; Ruiz M; Kang BY; Mehta JL; Beller GA; Glover DK; Meyer CH
Circ Cardiovasc Imaging; 2010 Jul; 3(4):464-72. PubMed ID: 20442371
[TBL] [Abstract][Full Text] [Related]
20. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform.
Cormode DP; Skajaa T; van Schooneveld MM; Koole R; Jarzyna P; Lobatto ME; Calcagno C; Barazza A; Gordon RE; Zanzonico P; Fisher EA; Fayad ZA; Mulder WJ
Nano Lett; 2008 Nov; 8(11):3715-23. PubMed ID: 18939808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
